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Abstract
Background: Efficient delivery strategies for health interventions are essential for high and sustainable coverage. We
report impact of a change in programmatic delivery strategy from routine delivery through the Expanded Programme on
Immunization (EPI+) approach to twice-yearly mass distribution campaigns on coverage of vitamin A supplementation in
Tanzania
Methods: We investigated disparities in age, sex, socio-economic status, nutritional status and maternal education
within vitamin A coverage in children between 1 and 2 years of age from two independent household level child health
surveys conducted (1) during a continuous universal targeting scheme based on routine EPI contacts for children aged 9,
15 and 21 months (1999); and (2) three years later after the introduction of twice-yearly vitamin A supplementation
campaigns for children aged 6 months to 5 years, a 6-monthly universal targeting scheme (2002). A representative cluster
sample of approximately 2,400 rural households was obtained from Rufiji, Morogoro Rural, Kilombero and Ulanga
districts. A modular questionnaire about the health of all children under the age of five was administered to consenting
heads of households and caretakers of children. Information on the use of child health interventions including vitamin A
was asked.
Results: Coverage of vitamin A supplementation among 1–2 year old children increased from 13% [95% CI 10–18%] in
1999 to 76% [95%CI 72–81%] in 2002. In 2002 knowledge of two or more child health danger signs was negatively
associated with vitamin A supplementation coverage (80% versus 70%) (p = 0.04). Nevertheless, we did not find any
disparities in coverage of vitamin A by district, gender, socio-economic status and DPT vaccinations.
Conclusion: Change in programmatic delivery of vitamin A supplementation was associated with a major improvement
in coverage in Tanzania that was been sustained by repeated campaigns for at least three years. There is a need to
monitor the effect of such campaigns on the routine health system and on equity of coverage. Documentation of vitamin
A supplementation campaign contacts on routine maternal and child health cards would be a simple step to facilitate this
monitoring.
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Background
Vitamin A supplementation is one of the best proven, saf-
est and most cost-effective interventions in public health
[1]. In populations where vitamin A deficiency is of public
health importance [2], vitamin A supplements are recom-
mended as prophylaxis and as treatment for at-risk groups
and sick individuals respectively. Approximately two-
thirds [3] of the 10.8 million child deaths [4] that pres-
ently occur can be prevented by available interventions of
which vitamin A supplementation (VAS) is one. A meta-
analysis of several large vitamin A trials has shown that
improving vitamin A status reduces mortality rates
between 23–34% among children six months to five years
of age if vitamin A supplementation is given at least twice
per year at coverage rates of at least eighty percent [5,6].
In Tanzania, efforts to combat vitamin A Deficiency
(VAD) started through a disease-targeted approach in
1987. This was confined to government-owned primary
health care facilities and targeted therapeutically to chil-
dren between 6–59 months suffering from xerophthalmia
or diseases precipitating VAD. Consequently, many young
children at risk of VAD in Tanzanian communities were
not treated with vitamin A. In 1997, Vitamin A supple-
mentation was introduced through the routine Essential
Drugs Programme (EDP) for post partum mothers' and
children at 9 months together with measles vaccination.
During measles vaccine campaigns in late 1999 and 2000,
children between 6–59 months from 30 and 52 districts
respectively of mainland Tanzania also received vitamin A
supplements. Post campaign vitamin A supplementation
coverage levels in these pilot campaigns were estimated at
94% and 99% in 1999 and 2000 respectively (Mugyabuso
JKL. paper presented at the Annual EPI evaluation meet-
ing 2002). Based on these results and similar lessons from
the Philippines [7], UNICEF initiated and supported the
national bi-annual implementation of VAS in children 6
months to 5 years in Tanzania starting in 2001. Advocacy,
social mobilization and campaigns through national
mass media agencies were used to create awareness in
communities. The estimated coverage for targeted chil-
dren in June and December 2001 from routine statistics
was 80% and 91% respectively (Mugyabuso JKL, paper
presented at the Annual EPI evaluation meeting 2001).
Here we describe the effect of the change in programmatic
delivery strategy of vitamin A supplementation on cover-
age as documented through two independent household-
level child health surveys carried out prior to the introduc-
tion of the twice-yearly mass distribution strategy (1999)
and three years later (2002). We also describe factors asso-
ciated with access to the intervention.
Methods
This study was part of a larger evaluation of the effective-
ness and cost of health system and facility-based Inte-
grated Management of Childhood Illness (IMCI). Details
of the study area have been described elsewhere [8]. In
brief, Rufiji and Kilombero districts are low-lying and
much of the land has fertile alluvial soil of the Rufiji and
Kilombero River plains respectively. Morogoro Rural and
Ulanga are mountainous with some low-lying areas. The
main economic activities of the population are subsist-
ence farming and fishing. The four districts have an esti-
mated total population of about 1.2 m people [9].
Morogoro Rural district participated in the measles vac-
cine campaign, which also included pilot vitamin A sup-
plementation in the late 1999 but not in 2000. Kilombero
district participated in the measles campaign with pilot
vitamin A supplementation in 2000. Rufiji and Ulanga
districts were not part of either pilot campaign.
A representative cluster sample of approximately 2,400
rural households was obtained from the four districts in
July–August 1999 and 2002. In 1999, 30 clusters were
selected from each of three districts and 35 clusters from
Kilombero District. Villages (clusters) were selected with
probability proportional to size, and one kitongoji (sub-
village with approximately 100 households) was selected
at random from each selected village. 20 households were
selected using a modified EPI-type scheme [10] that guar-
anteed an equal probability of selection for every house-
hold. In 2002, the same villages were selected but the
sampling of sub-villages and households was repeated
with replacement. The chances of visiting the same house-
holds were small. Ifakara town in Kilombero district is the
largest urban area in the survey: ten additional clusters
from this town have been omitted from the analysis
described here, so that all results refer to rural areas.
A structured questionnaire about the health of all children
under the age of five years was administered to consenting
heads of the households. We documented background
information of all children in the household, information
on proxy indicators of household socio-economic status
such as household ownership of a radio, a tin roof, a bicy-
cle, educational level and occupation of the head of
household. Mothers or caretakers of children were inter-
viewed about their educational level and knowledge of
child health danger signs (fast breathing, difficult breath-
ing, fits or convulsions, very sleepy, vomiting all ingested
material or inability to drink or breastfeed). Vaccination
history was recorded from health cards or mother's record
books for those who had one. Where no could be found,
mothers or caretakers were asked whether the child had
DPT immunizations and the number of doses received.
Mothers or caretakers were shown a vitamin A capsule and
were asked whether their children had ever received a sim-
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ilar one, and if so, the month and year of the most recent
dose.
The study received ethical clearance from the institutional
review board of the Ifakara Health Research and Develop-
ment Centre and the national Tanzanian Medical
Research Coordinating Committee.
Data analysis
Data were double-entered and verified using FoxPro (ver-
sion 2.6, Microsoft Corporation, Seattle, WA, USA) at
Ifakara Health Research and Development Centre
(IHRDC). Range checks and internal consistency were
performed before analysis in Stata (version 8.2, Stata Cor-
poration, College Station, TX, USA).
Since villages (clusters) were our unit of sampling, indi-
vidual analysis methods were not appropriate due to arti-
ficially small standard errors. Hence we employed cluster-
sampling analysis methods in STATA to obtain correct
standard errors and confidence intervals for our parameter
estimates [11-13]. We used standard STATA svytab com-
mand to produce design-based F-tests. Vitamin A supple-
mentation coverage was defined as the number of
children between 1 and 2 years of age receiving vitamin A
in the six months prior to the date of the survey divided
by the total number of children between 1 and 2 years in
the survey [14]. A relative index of socio-economic status
was constructed by combining documentation of house-
hold characteristics (type of roof), assets (house owner-
ship, bicycle, net, animals, and fowls), income sources
(income of head apart from farming, maternal income)
and education (head and maternal education). We used
principal components analysis to estimate the appropri-
ate weights or "scores" for the index [15]. Quintiles of
children were developed based on their household socio-
economic score.
Results
A total of 385 and 388 children aged between 1 and 2
years who had complete data on vitamin A supplementa-
tion were sampled from 2,131 and 2,027 households in
1999 and 2002 surveys respectively. Table 1 shows
selected background of the study subjects from the two
surveys. Approximately 1% (1999) and 0.4% (2002) of
the households refused to participate in the surveys.
Overall coverage of vitamin A increased from 13.2% [95%
CI: 9.8–17.7%] in 1999 to 76.3% [95% CI: 71.5–80.5%]
(Table 2). As expected, maternal education was associated
with VAS coverage, although the difference reached con-
ventional statistical significance only in 1999 (p = 0.02),
and not in 2002 (p = 0.08). Coverage of VAS was similar
in the two surveys for both boys and girls and did not vary
by vaccination status. However, in the 2002 survey, mater-
nal knowledge on child health danger signs was found to
be negatively associated with VAS coverage, which was
about 10 percentage points lower in mothers who knew at
least two danger signs than in those who did not. The VAS
achieved a major increase in coverage without any
decrease in socio-economic equity: coverage was uni-
formly distributed by socio-economic status before and
after the campaigns, as well as across the districts.
Multivariate analysis of the association between maternal
education, knowledge of danger signs and vitamin A sup-
plementation gave similar conclusions (data not shown).
Discussion
This study has revealed that a change in the delivery strat-
egy of interventions in a health system can have important
effects on coverage without compromising equity. Our
data has shown that vitamin A supplementation coverage
in children between 1 and 2 years of age increased from
13% in 1999 to 76% in 2002. National coverage figures
from the 1999 Tanzania Reproductive and Child Heath
Survey (TRCHS) were similar (14%) [16] to what we
observed in study districts. However more recent national
coverage estimates from the 2004/2005 DHS, which
includes around 7,000 children [17], are rather lower at
(46%), than we found in our 2002 survey. These differ-
ences could be due to geographic variations in coverage or
to a drop between 2002 and 2004. In contrast, 85% and
90% coverage at national level have been recently
reported by two other sources (Ndossi, G.D. 2004 and
Helen Keller International, 2004), the second of which
was a population based assessment in 12,000 children
from 21 regions of mainland Tanzania. The most likely
explanation for the discrepancies between the 2004/05
DHS and HKI surveys, both of which cover the entire
country, are a combination of survey timing and differ-
ences in questionnaires wording and implementation.
The HKI survey was conducted during August 2004, and
had a short recall period, as it was little more than a
month after the June 2004 VAS campaign. The DHS was
conducted from October 2004 to January 2005. Further,
the HKI survey question on VAS had a specific point refer-
ence of June 2004 whereas the DHS question referred to a
6 month period prior to the survey (giving the scope to
capture VAS provided through EPI+ as well as disease tar-
geted approaches, which would have increased coverage
estimates). Interview techniques, whether or not mothers
were actually shown the capsules, and whether the cap-
sules shown were of the right colour, could also help to
explain the differences observed (Mugyabuso, report in
preparation). Sampling methodology also differed
between the surveys.
We found no evidence of socio-economic inequities in
vitamin A supplementation in either 1999 or 2002,
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despite the major increase in coverage, unlike what has
been reported elsewhere [18]. By socio-economic inequity
in VAS we mean the trend in coverage level across socio-
economic quintiles. New health interventions are often
embraced by the richest first and followed gradually by
the poorest [19]. So that one would expect equity to get
worse as coverage increases before it can get better. Here
we found no evidence of increased inequity despite a
major increase in coverage and this highlights the need for
devising ways to maintain these achievements [20]. We
did not find any evidence of gender or district differentials
in VAS coverage. Our results on the lack evidence of ineq-
uity in gender are similar to what was reported by Bishai
and colleagues [21]. A negative association between vita-
min A supplementation and maternal knowledge of child
health danger signs was rather unexpected and think it is
likely to be a chance finding than a real difference.
Vitamin A supplementation campaigns in Tanzania have
been concerted efforts by the Government and stakehold-
ers from the health sector. To maximize coverage, activi-
ties were strategically integrated into commemoration of
the Day of the African Child and World AIDS Day events.
During implementation, partnerships were forged
between the Presidents Office for Regional Administra-
tion and Local Government (PORALG), Ministry of
Health and the Tanzania Food and Nutrition Centre
(TFNC). Funding support came primarily from UNICEF
and vitamin A supplies from Canadian International
Development Agency (CIDA). Other agencies and Non
Governmental Organizations such as USAID and Plan
International also joined these efforts, albeit in later
rounds.
This study had two potential limitations. First, we
depended largely on the mothers' or caretakers' accounts
of the vitamin A supplementation status of their children.
Table 1: Age, sex, maternal education and socioeconomic status of study population in 1999 and 2002 surveys
Characteristics Survey year
1999 2002
n % n %
Sex (N = 385 in 1999, 388 in 2002)
Female 197 51.2 183 47.2
Male 188 48.8 205 52.8
Age distribution‡
6–11 months 467 25.2 401 21.3
1–2 years 385 20.7 388 20.6
2–3 years 353 19.0 406 21.6
3–4 years 348 18.7 356 19.0
4–5 years 304 16.4 330 17.5
DPT vaccination (N = 385 in 1999, 387 in 2002)
Not vaccinated 105 27.3 91 23.5
Vaccinated 280 72.7 296 76.5
Mothers education (N = 385 in 1999, 388 in 2002)
None 129 33.5 100 25.7
Primary 243 63.1 280 72.2
Secondary/Higher 13 3.4 8 2.1
Knowledge of ≥2 danger signs (N = 353 in 1999, 375 in 2002)
No 281 79.9 244 65.1
Yes 71 20.1 131 34.9
Wealth quintiles (N = 350 in 1999, 376 in 2002)
Poorest 60 17.1 73 19.4
Second poorest 56 16.0 77 20.5
Middle 80 22.9 70 18.6
Second richest 73 20.9 82 21.8
Richest 81 23.1 74 19.7
District (N = 385 in 1999, 388 in 2002)
Morogoro 79 20.5 95 24.5
Rufiji 99 25.7 108 27.8
Ulanga 111 28.8 114 29.4
Kilombero 96 25.0 71 18.3
‡ All children under five year included here
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We also checked the child's MCH card or notebook for
information about vitamin A supplementation but this
had limited use as the campaign staff were trained not to
record the vitamin A dose on the children's health cards.
Secondly, neither the 1999 nor the 2002 household sur-
veys were designed solely to evaluate the change in deliv-
ery strategy or policy, but were rather designed to measure
coverage of various interventions for children under five,
vitamin A supplementation being one, as recommended
by UNICEF and WHO [14]. Thirdly, the increase in vita-
min A supplementation coverage may have been due in
part to other factors and not to the change in the delivery
strategy above. However, we are not aware of any factors
that could be responsible for the dramatic increase in cov-
erage despite a comprehensive investigation of contextual
factors [22,23]
Although the bi-annual campaign-based strategy for vita-
min A delivery resulted in a major increase in coverage, it
remains important that this approach sustains universal
coverage while not undermining routine health programs
[24].
One among the many obstacles for health systems in low-
income countries is fragmented health information sys-
tems. Reliable and timely health information is an essen-
tial foundation for public health action. Such systems are
vital for informing decision-makers to enable them to
identify problems and needs, track progress, evaluate the
impact of interventions, and make evidence-based deci-
sions on health policy and effect policy change. Routine
health programs may be weak due to poorly motivated
and often overburdened health staffs, whose job includes
reporting from multiple data collection systems and who
suffer and who suffer from a lack of supervision. The VAS
coverage rates that we have observed so far in Tanzania
need to be sustained and monitored regularly if we are to
reach the MDGs in 2015. The MCH "Road to Health"
cards offer a practical opportunity to capture information
on interventions that children actually receive through
routine systems or campaigns.
During the mass distribution campaigns, vitamin A sup-
plementation was not recorded on the health card. If cam-
paigns are going to continue, monitoring of progress
would be greatly simplified if planners ensure that infor-
Table 2: Vitamin A coverage in children (12–23 months) by selected characteristics in 1999 and 2002
Characteristics 1999 Survey 2002 Survey
n N % 95%CI p valuea n N % 95%CI p valuea
VAS coverage
All districts 51 385 13.2 9.8–17.7 296 388 76.3 71.5–80.5
Sex
Male 27 188 14.4 9.8–20.5 0.53 161 205 78.5 71.8–93.9 0.28
Female 24 197 12.2 7.9–18.4 135 183 73.8 66.8–79.7
DPT vaccination
Vaccinated 37 280 13.2 9.5–18.1 0.97 229 296 77.4 71.6–82.3 0.34
Not vaccinated 14 105 13.3 7.6–22.3 66 91 72.5 63.2–80.2
Maternal education
No 10 129 7.8 4.2–13.8 0.02 70 100 70.0 60.2–78.3 0.08
Primary 37 243 15.2 11.2–20.3 218 280 77.9 72.4–82.5
Secondary 4 13 30.8 12.0–59.1 8 8 100.0 -
Knowledge of ≥2 danger signs
No 35 282 12.4 9.1–16.8 0.09 195 244 79.9 74.4–84.5 0.04
Yes 14 71 19.4 11.5–31.8 91 131 69.5 60.0–77.6
Socio-economic status
Poorest 5 60 8.3 3.7–17.8 0.64b 56 73 76.7 67.5–84.0 0.68b
Very Poor 10 56 17.9 9.6–30.9 59 77 76.6 65.5–85.0
Poor 9 80 11.3 5.7–21.1 49 70 70.0 56.7–80.6
Less Poor 10 73 13.7 6.7–26.0 65 82 79.3 68.7–86.9
Least Poor 12 81 14.8 8.1–25.5 58 74 78.4 67.6–86.3
District
Morogoro 12 79 15.2 8.2–26.5 0.85 73 95 76.8 66.9–84.5 0.94
Rufiji 13 99 13.1 6.6–24.3 81 108 75.0 65.3–82.7
Ulanga 16 111 14.4 8.4–23.6 89 114 78.1 69.3–84.9
Kilombero 10 96 10.4 5.5–18.9 53 71 74.6 61.6–84.4
a Pearson chi-squared statistics corrected for survey design
b P-level for F-test for linear trend in proportions, using logistic regression adjusting for clustering
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mation for each individual child is recorded. To our
knowledge, vaccines or vitamin A supplementation cam-
paigns that are outside routine EPI are not generally regis-
tered on children's health cards.
Coverage figures of the campaigns since 2001 have been
recorded on tally sheets and subsequently summary
sheets that were later collated by Tanzania Food and
Nutrition Centre. The problem with this approach is the
potential to over-estimate coverage because of lack of
proper denominators, or inflated numerators due to mul-
tiple doses to the same children. Documenting any extra
contacts such as National Immunization Days (NID) or
other related health events on health cards not only offers
a useful opportunity to reliably estimate coverage figures,
but also creates a less demanding and more integrated
health information system. In our study, we used infor-
mation provided by mothers as well as that written on
health cards to estimate coverage figures. This source of
information is also open to error but is likely to be a con-
servative estimate, and has the advantage of being house-
hold-based [25].
Social mobilization campaigns are good for catch-up cov-
erage over a short period of time. This coverage has been
sustained for at least three years. In spite of the campaigns,
national VAS coverage may have dropped as low as 46%
in 2004 [17]. Given the evidence on the cost per death
averted in Tanzania [26] and the role vitamin A can play
in reducing child mortality, allocation of resources
required to implement such child health interventions
needs to be maintained.
Conclusion
We conclude that, since routine services at present are not
geared towards monitoring vitamin A supplementation
campaign contacts, deliberate efforts must be taken to
enable capturing of such information at both routine con-
tacts and campaigns. This will facilitate the monitoring of
the effect of campaigns on routine health systems, equity
of coverage and tracking progress on child survival.
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